IN THE NEWS

David Purinton Joins VERTESS as Managing Director

Published September 24th 2021 Originally Published by Cision PR Newswire September 16th 2021

FORT WORTH, Texas, Sept. 16, 2021 /PRNewswire/ -- VERTESS, a leading healthcare mergers and acquisitions (M+A) advisory firm (https://vertess.com), announced today that David Purinton, an experienced leader in drug and alcohol recovery services as well as financial consulting, has joined the company as a Managing Director. David began his career in corporate M+A and financial advisory services with a full-service investment bank and then a consulting agency serving investment banks, private equity groups, and operating companies.

After a decade of experience as both a client of and consultant to SUD treatment providers, David was interested in improving access to high quality treatment. As a result, he co-founded Spero Recovery, a provider of low-cost, high-quality drug and alcohol recovery services with over 100 beds in its continuum of residential, outpatient, and sober living care. Spero Recovery, based in Colorado, is a residential SUD treatment environment with upscale amenities and personalized care.  As its CFO, David led the company to significant revenue and margin growth while ensuring it adhered to the strictest principles of integrity and client care. After selling Spero, David remained in a leadership position with new ownership as its CFO and quickly realized accretion and integration.

While working full-time, David earned his MBA from the University of Denver with Distinction and a Concentration in Corporate Finance.  As a business leader, David focused on the importance of investing in his staff and clients. He understood that the numbers on a spreadsheet represent humans, families, and dreams, which was a radically different paradigm from investment banking.

At VERTESS, David will provide M+A and consulting services primarily to the Behavioral Health and Substance Use Disorder treatment markets, where he brings a foundation of financial expertise with the value-add of humanness and care for the business owners he represents. 

"As a co-founder, I put my employees' and clients' needs above my own," David stated, "and I found that the inherent values of the VERTESS team are in complete alignment. They not only have a proven track record of success, but they truly care about their clients and the people whom their clients serve. VERTESS exceeded all of my expectations with regard to a client-centered approach to M+A advisory, and I am both honored and humbled to be on this team of exceptional professionals." 

Brad Smith, VERTESS Managing Director/Partner, said, "David's well-balanced background in both M+A and finance, as well as founding and operating a successful treatment facility is a tremendous asset to our team.  I believe David's empathetic and common-sense approach to helping other business owners will be a game changer for us."

David Purinton can be reached directly at [email protected] or +1.720.626.2500.

Continue Reading

MORE NEWS

Quality of Earnings: The Big Obstacle to Healthcare Deal Success

A lot of merger and acquisition (M+A) deals fail. That's been the case for a long time. The M+A failure rate that's freq...
Read More

VERTESS Answers: Why Do I Need to Market My Company to Buyers?

If you own a healthcare company, you are probably receiving inquiries from interested buyers. We view this as buyers mar...
Read More

6 Recommendations To Run a Better ASC and Achieve a Successful Sale

Preparing an ambulatory surgery center (ASC) for a sale is a worthwhile process for center owners regardless of whether ...
Read More

Hospital at Home: A Shift in the Healthcare System

We're seeing a notable shift occurring in healthcare. While we have largely focused on how to enhance care delivery with...
Read More

VERTESS Answers: Should I Work With a Healthcare Advisor or Broker?

We will occasionally hear from the owner of a healthcare company something along the lines of the following: "I know som...
Read More

Parallels Between Early Clinical and Early Transaction Intervention

My educational and professional experiences have demonstrated to me the importance and value of early intervention, both...
Read More

Corporate Transparency Act: What It Is and What You Need To Do

The Corporate Transparency Act (CTA) went into effect on Jan. 1, 2024. This federal reporting requirement affects millio...
Read More

Are You Ready to Sell Your Healthcare Company?

After spending many years building your healthcare company, it's increasingly likely that you will find yourself thinkin...
Read More

David Coit Earns CBEC Designation

FORT WORTH, Texas, Sept. 15, 2020 /PRNewswire/ -- VERTESS mergers and acquisitions (M&A) advisor...
Read More

The Art of the Deal: Finding the Right Buyer & Understanding Your Business’s Value With Bradley Smith

VERTESS Managing Director/Partner, Bradley Smith, recently participated in a podcast hosted by MCM Wealth. In this episo...
Read More

Secrets You Need to Succeed in the DME Industry

By Bradley Smith, ATP, CM&AA Volume 3 Issue 22, October 25, 2016 Several years ago, DME competitive bidding was inst...
Read More
1 2 3 26

COMMITTED TO CONSTANT IMPROVEMENT?

Want to stay current with trends in the medical/healthcare space as well as receive expert advice of veteran medical entrepreneurs?
SUBSCRIBE TO OUR BI-WEEKLY NEWSLETTER VERTESSPRESS
For over 10 years, we've been teaching ways you can improve the value of your healthcare company, focusing on informing you about mergers + acquisitions, including M+A trends in the healthcare market.
CHECK OUT VERTESSPRESS THE BLOG
No Spam Ever. We Promise
©2024 VERTESS. All Rights Reserved.